NO20033305L - Nytt filmbelegg - Google Patents

Nytt filmbelegg

Info

Publication number
NO20033305L
NO20033305L NO20033305A NO20033305A NO20033305L NO 20033305 L NO20033305 L NO 20033305L NO 20033305 A NO20033305 A NO 20033305A NO 20033305 A NO20033305 A NO 20033305A NO 20033305 L NO20033305 L NO 20033305L
Authority
NO
Norway
Prior art keywords
film coating
film
core
coating composition
pharmaceutical
Prior art date
Application number
NO20033305A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033305D0 (no
Inventor
Arne Hoelzer
Jan-Erik Loefroth
Staffan Schantz
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20033305D0 publication Critical patent/NO20033305D0/no
Publication of NO20033305L publication Critical patent/NO20033305L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
  • Laminated Bodies (AREA)
NO20033305A 2001-01-24 2003-07-22 Nytt filmbelegg NO20033305L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating
PCT/SE2002/000103 WO2002058677A1 (en) 2001-01-24 2002-01-22 New film coating

Publications (2)

Publication Number Publication Date
NO20033305D0 NO20033305D0 (no) 2003-07-22
NO20033305L true NO20033305L (no) 2003-07-22

Family

ID=20282714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033305A NO20033305L (no) 2001-01-24 2003-07-22 Nytt filmbelegg

Country Status (21)

Country Link
US (1) US7959947B2 (cg-RX-API-DMAC10.html)
EP (1) EP1355635B1 (cg-RX-API-DMAC10.html)
JP (1) JP4303471B2 (cg-RX-API-DMAC10.html)
KR (1) KR100874582B1 (cg-RX-API-DMAC10.html)
CN (1) CN1218692C (cg-RX-API-DMAC10.html)
AT (1) ATE285229T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002225573B2 (cg-RX-API-DMAC10.html)
BR (1) BR0206515A (cg-RX-API-DMAC10.html)
CA (1) CA2433530A1 (cg-RX-API-DMAC10.html)
DE (2) DE20220901U1 (cg-RX-API-DMAC10.html)
DK (1) DK1355635T3 (cg-RX-API-DMAC10.html)
ES (1) ES2233804T3 (cg-RX-API-DMAC10.html)
IL (2) IL156623A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03006419A (cg-RX-API-DMAC10.html)
NO (1) NO20033305L (cg-RX-API-DMAC10.html)
NZ (1) NZ526792A (cg-RX-API-DMAC10.html)
PT (1) PT1355635E (cg-RX-API-DMAC10.html)
SE (1) SE0100200D0 (cg-RX-API-DMAC10.html)
SI (1) SI1355635T1 (cg-RX-API-DMAC10.html)
WO (1) WO2002058677A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200305457B (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DK1355633T3 (da) * 2001-12-19 2005-04-04 Astrazeneca Ab Ny filmcoating, der indeholder en ethylacrylat/methylmethacrylat-copolymer og polyvinylacetat
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
AU2003211146B2 (en) * 2002-02-21 2007-07-19 Valeant International (Barbados) Srl Controlled release dosage forms
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
EP1589957A1 (en) * 2003-02-05 2005-11-02 IPCA Laboratories Limited Pharmaceutical compositions and process of production thereof
BRPI0415557A (pt) * 2003-10-31 2006-12-26 Hexal Ag formulação contendo ingrediente ativo farmacêutico com revestimento
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
EP2564839B1 (en) 2009-01-09 2016-05-11 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
EP2379062A1 (en) * 2009-01-09 2011-10-26 Forward Pharma A/S Pharmaceutical composition comprising one or more fumaric acid esters
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
JP6397813B2 (ja) 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
RU2015138784A (ru) 2013-02-13 2017-03-17 Эвоник Рем ГмбХ Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
CN105085778B (zh) * 2014-04-22 2018-11-16 广东华润涂料有限公司 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用
HUE055974T2 (hu) 2015-03-03 2022-01-28 Saniona As Tesofensine és metoprolol kombinációs készítmény
SG11201811579VA (en) * 2016-06-30 2019-01-30 Beckman Coulter Inc Chemiluminescent substrates
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
WO2026046944A1 (en) * 2024-08-27 2026-03-05 Basf Se Coating composition and coated tablet

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
JP2782691B2 (ja) 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
JP2558396B2 (ja) 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DK1355633T3 (da) * 2001-12-19 2005-04-04 Astrazeneca Ab Ny filmcoating, der indeholder en ethylacrylat/methylmethacrylat-copolymer og polyvinylacetat
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
JP4303471B2 (ja) 2009-07-29
ES2233804T3 (es) 2005-06-16
BR0206515A (pt) 2004-02-17
DK1355635T3 (da) 2005-03-29
ZA200305457B (en) 2004-10-15
DE60202351D1 (de) 2005-01-27
CN1218692C (zh) 2005-09-14
CN1487828A (zh) 2004-04-07
KR20030070122A (ko) 2003-08-27
DE60202351T2 (de) 2005-12-01
PT1355635E (pt) 2005-04-29
IL156623A (en) 2007-12-03
EP1355635A1 (en) 2003-10-29
CA2433530A1 (en) 2002-08-01
KR100874582B1 (ko) 2008-12-16
JP2004522741A (ja) 2004-07-29
IL156623A0 (en) 2004-01-04
SE0100200D0 (sv) 2001-01-24
US7959947B2 (en) 2011-06-14
WO2002058677A1 (en) 2002-08-01
MXPA03006419A (es) 2003-10-15
SI1355635T1 (en) 2005-06-30
DE20220901U1 (de) 2004-06-17
NO20033305D0 (no) 2003-07-22
ATE285229T1 (de) 2005-01-15
EP1355635B1 (en) 2004-12-22
HK1063432A1 (en) 2004-12-31
AU2002225573B2 (en) 2006-09-07
US20040058001A1 (en) 2004-03-25
NZ526792A (en) 2004-12-24

Similar Documents

Publication Publication Date Title
NO20033305D0 (no) Nytt filmbelegg
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
CA2290531A1 (en) Pharmaceutical formulation of omeprazole
SE9803772D0 (sv) Pharmaceutical formulation
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
EP1803473A3 (en) Adhesive including medicament
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
ATE184196T1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
MY129350A (en) Aripiprazole oral solution
EP1690530A3 (en) Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
WO2003002136A3 (en) Stable formulation of modified glp-1
CA2208230A1 (en) Controlled release formulation (albuterol)
WO2005027843A3 (en) Chronotherapeutic dosage forms
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
NO20031409L (no) Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse
ATE286736T1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
AU2002304784A1 (en) Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
BR0115206A (pt) Composições hidroliticamente instáveis
EP1245562A4 (en) ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
WO2003035043A3 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
AU2001274000A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application